The global sample preparation station market was valued at USD 3420 million in 2025 and is projected to reach USD 3687 million in 2026. By 2034 it is forecast to stand at USD 6725 million, a compound annual growth rate of 7.81% over the forecast period, according to a new Contrive Datum Insights study.
Where Buyers Are Putting Their Money
By end user, Hospitals & Diagnostic Laboratories led in 2025 with 38.01% of revenue, or USD 1300 million. Contract Research Organizations is the fastest-growing buyer group at 9.67% a year, ahead of the market as a whole.
Automation level shows the clearest shift in purchasing. Semi-Automated systems took 45% of 2025 revenue at USD 1539 million, yet Fully Automated platforms grow fastest at 12.94%. Buyers are still choosing partial automation today and moving toward walk-away operation as budgets allow.
By type, Liquid Handling is the largest line at 24.01% of 2025 revenue and USD 821 million, and it is expected to hold 27% in 2034. Hybridization is the quickest mover, compounding at 12.07% and lifting its share of revenue from 6.99% to 9.99%, with its value climbing from USD 239 million to USD 672 million. Staining carries 18.01% of 2025 revenue but grows at only 6.4%, slower than the market overall.
Diagnostic work accounts for most application spending, at 41.99% of 2025 revenue and USD 1436 million, while Research grows fastest at 8.76%. By sample type, Blood & Biological Fluids led with 48.01% of revenue at USD 1642 million, and Environmental & Industrial Samples is the fastest line at 10.01%.
Geographically, the United States is the largest single country market at USD 982 million in 2025, or 28.71% of global revenue. All five regions are covered to country level in the study.
Growth Outlook
Automation and walk-away sample processing in clinical and pharmaceutical laboratories is the largest single contributor to growth over the forecast period, and the study rates its impact high. A faster shift to fully automated platforms in pharmaceutical and biotechnology manufacturing would pull capital spending forward and take 2034 revenue to USD 7633 million. If laboratory capital budgets tighten and hospital groups stretch the replacement cycles of their manual and semi-automated equipment, 2034 revenue would hold at USD 5999 million. The base case of USD 6725 million sits between the two.
The study covers five segmentation axes (type, application, end user, automation level and sample type), with a revenue figure and a growth rate for every line in every year from 2020 to 2034. It also includes the competitive landscape and the methodology behind each estimate. The report is delivered as a PDF, and a free sample can be requested.